RecruitingPhase 2Phase 3NCT04351347
The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
Clinical Study Evaluating the Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
Sponsor
Tanta University
Enrollment
300 participants
Start Date
Jun 16, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
Efficacy of Ivermectin in larger doses in COVID-19 treatment
Eligibility
Inclusion Criteria1
- Patients with covid 19
Exclusion Criteria1
- Allergy or side effects to treatment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGIvermectin
ivermectin
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04351347
Related Trials
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
NCT0491026966 locations
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
NCT072210976 locations
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
NCT067446603 locations
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
NCT043621501 location
A Study to Explore the Role of Gut Flora in COVID-19 Infection
NCT043598361 location